Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	1	5	15	0	0
Revenue Growth (YoY)	-80.00%	-66.67%	-	-	-
Gross Profit	1	5	15	0	0
Selling, General & Admin	15.93	15.72	12.4	10.29	7
Research & Development	31.05	39.83	38.67	34.49	41.99
Other Operating Expenses	15.11	9.1	7	5.94	8.89
Operating Expenses	62.1	64.64	58.07	50.71	57.88
Operating Income	-61.1	-59.64	-43.07	-50.71	-57.88
Interest Expense / Income	2.55	0	0	0	0
Other Expense / Income	-3.97	-1.25	-0.22	-0.73	-2.6
Pretax Income	-59.69	-58.39	-42.85	-49.98	-55.29
Income Tax	0	0	0	-0.02	-0.06
Net Income	-59.69	-58.39	-42.85	-49.97	-55.23
Shares Outstanding (Basic)	43	42	42	29	16
Shares Outstanding (Diluted)	43	42	42	29	16
Shares Change	1.19%	1.47%	42.56%	85.91%	4845.07%
EPS (Basic)	-1.39	-1.38	-1.02	-1.70	-3.50
EPS (Diluted)	-1.39	-1.38	-1.02	-1.70	-3.50
Free Cash Flow	-46.54	-52.74	-33.22	-50.73	-51.57
Free Cash Flow Per Share	-1.08	-1.24	-0.79	-1.73	-3.27
Gross Margin	100.00%	100.00%	100.00%	-	-
Operating Margin	-6109.80%	-1192.84%	-287.15%	-	-
Profit Margin	-5968.50%	-1167.76%	-285.69%	-	-
Free Cash Flow Margin	-4653.60%	-1054.82%	-221.49%	-	-
EBITDA	-57.04	-58.3	-42.76	-49.89	-55.25
EBITDA Margin	-5703.90%	-1165.98%	-285.07%	-	-
Depreciation & Amortization	0.09	0.09	0.09	0.1	0.04
EBIT	-57.13	-58.39	-42.85	-49.98	-55.29
EBIT Margin	-5713.10%	-1167.76%	-285.69%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).